Hanall Biopharma Co.,Ltd (009420.KS)

KRW 32650.0

(-6.18%)

Long Term Debt Summary of Hanall Biopharma Co.,Ltd

  • Hanall Biopharma Co.,Ltd's latest annual long term debt in 2023 was 590.3 Million KRW , down -21.4% from previous year.
  • Hanall Biopharma Co.,Ltd's latest quarterly long term debt in 2024 Q2 was - KRW , down 0.0% from previous quarter.
  • Hanall Biopharma Co.,Ltd reported annual long term debt of 751.05 Million KRW in 2022, down -17.62% from previous year.
  • Hanall Biopharma Co.,Ltd reported annual long term debt of 911.67 Million KRW in 2021, up 229.41% from previous year.
  • Hanall Biopharma Co.,Ltd reported quarterly long term debt of 603.56 Million KRW for 2024 Q1, down -100.0% from previous quarter.
  • Hanall Biopharma Co.,Ltd reported quarterly long term debt of 576.75 Million KRW for 2023 Q3, down -14.53% from previous quarter.

Annual Long Term Debt Chart of Hanall Biopharma Co.,Ltd (2023 - 2007)

Historical Annual Long Term Debt of Hanall Biopharma Co.,Ltd (2023 - 2007)

Year Long Term Debt Long Term Debt Growth
2023 590.3 Million KRW -21.4%
2022 751.05 Million KRW -17.62%
2021 911.67 Million KRW 229.41%
2020 276.75 Million KRW 37.9%
2019 200.69 Million KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%
2015 - KRW -100.0%
2014 3 Billion KRW 0.0%
2013 - KRW 0.0%
2012 - KRW -100.0%
2011 6.79 Billion KRW -21.73%
2010 8.68 Billion KRW -60.21%
2009 21.81 Billion KRW -1.79%
2008 22.21 Billion KRW 102.22%
2007 10.98 Billion KRW 0.0%

Peer Long Term Debt Comparison of Hanall Biopharma Co.,Ltd

Name Long Term Debt Long Term Debt Difference
Yuyu Pharma, Inc. 13.64 Billion KRW 95.672%
Dong-A Socio Holdings Co., Ltd. 202.06 Billion KRW 99.708%
Ildong Holdings Co., Ltd. 29.87 Billion KRW 98.024%
HANDOK Inc. 123.78 Billion KRW 99.523%
Kukje Pharma Co., Ltd. 475.74 Million KRW -24.082%
Yuhan Corporation 60.23 Billion KRW 99.02%
Dong-A ST Co., Ltd. 161.99 Billion KRW 99.636%
SAMSUNG PHARM. Co., LTD. 101.81 Million KRW -479.77%
Hanmi Pharm. Co., Ltd. 82.02 Billion KRW 99.28%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW 90.243%
Dong Sung Bio Pharm.Co.,Ltd. 18.52 Billion KRW 96.813%
MYUNGMOON Pharm co.,Ltd 12.58 Billion KRW 95.309%
Hana Pharm Co., Ltd. 1.59 Billion KRW 63.079%
Yuyu Pharma, Inc. 13.64 Billion KRW 95.672%
Ilsung Pharmaceuticals Co., Ltd. 119.67 Million KRW -393.246%
REYON Pharmaceutical Co., Ltd. 121 Billion KRW 99.512%
Aprogen pharmaceuticals,Inc. 32 Billion KRW 98.155%
JW Holdings Corporation 20.65 Billion KRW 97.142%
Ildong Pharmaceutical Co., Ltd. 14.82 Billion KRW 96.018%
Chong Kun Dang Pharmaceutical Corp. 30 Billion KRW 98.032%
JW Pharmaceutical Corporation 30 Billion KRW 98.032%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -169.596%
Hyundai Pharmaceutical Co., Ltd. 580.64 Million KRW -1.664%
Samil Pharmaceutical Co.,Ltd 49.56 Billion KRW 98.809%
Jeil Pharmaceutical Co.,Ltd 4.45 Billion KRW 86.741%
Yuyu Pharma, Inc. 13.64 Billion KRW 95.672%
Kwang Dong Pharmaceutical Co., Ltd. 19.02 Billion KRW 96.898%
Daewoong pharmaceutical Co.,Ltd 93.41 Billion KRW 99.368%
JW Pharmaceutical Corporation 30 Billion KRW 98.032%
Yuhan Corporation 60.23 Billion KRW 99.02%
Jeil Pharma Holdings Inc 10.5 Billion KRW 94.378%
Yungjin Pharm. Co., Ltd. 40.37 Billion KRW 98.538%
Suheung Co., Ltd. 74 Billion KRW 99.202%
JW Pharmaceutical Corporation 30 Billion KRW 98.032%
Samjin Pharmaceuticals Co., Ltd. 4.16 Billion KRW 85.832%
Korea United Pharm Inc. 10.96 Billion KRW 94.615%
CKD Bio Corp. 69.43 Billion KRW 99.15%
Daewon Pharmaceutical Co., Ltd. 34.57 Billion KRW 98.293%
Dongwha Pharm.Co.,Ltd 16.12 Billion KRW 96.34%
Whan In Pharm Co.,Ltd. 307.05 Million KRW -92.248%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -169.596%
Chong Kun Dang Holdings Corp. 72.11 Billion KRW 99.181%
Boryung Corporation 151.7 Billion KRW 99.611%
Bukwang Pharmaceutical Co., Ltd. 78.52 Billion KRW 99.248%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW 90.243%
JW Lifescience Corporation 168 Million KRW -251.375%